Author(s): Varsha Bandil, Jeetendra Kumar Gupta, Manoj Goyal


DOI: 10.5958/0974-360X.2021.00323.1   

Address: Varsha Bandil1*, Jeetendra Kumar Gupta1, Manoj Goyal2
1Institute of Pharmaceutical Research, GLA University, Mathura, U.P. 281406, India.
2Jai Institute of Pharmaceutical Sciences and Research, Vism Campus, Gwalior, M.P. 474001, India.
*Corresponding Author

Published In:   Volume - 14,      Issue - 3,     Year - 2021

Vinorelbine is a semi synthetic vinca organic compound that has been exposed dynamic in numerous tumor types and is right now enrolled for the cure of advanced breast cancer (ABC) and non-small cell lung cancer (NSCLC). Evaluation of its pharmacokinetic and toxic outline and give understanding into its future as a NSCLC and ABC remedial. Its marketed formulation has been accounted for to have serious aspect effects, like venous irritation and phlebitis proximal to the site of infusions, likewise restricted rashes and urticaria. Our long run aim in synthesizing a novel nanomicellar vinorelbine formulation is to decrease or perhaps eliminate these adverse effect and increment medicate action by formulating the medication in a lipid-based framework as a nanomedicine focused to the location of activity.

Cite this article:
Varsha Bandil, Jeetendra Kumar Gupta, Manoj Goyal. Vinorelbine: A Potential Breakthrough in Cancer Therapy. Research J. Pharm. and Tech 2021; 14(3):1823-1827. doi: 10.5958/0974-360X.2021.00323.1

1.    Johnson SAN. Vinorelbine: an update and review of activity. Clin. Oncology. 1996; 8: 353.
2.    Brunello A, Rome A, Basso U and Jirillo A. A review of vinorelbine in the treatment of advanced breast cancer. Clin. Med.: Therapeutics. 2009; 1: 1716.
3.    Gregory RK and Smith IE. Vinorelbine-a clinical review. Br. J. Cancer. 2000; 82(12): 1907, 1908.
4.    Drug bank, Vinorelbine: DB00361.
5.    Breast Cancer Now, the research and care charity: https:// going-through-treatment-breast-cancer/chemotherapy/ vinorelbine-navelbine.
6.    Cancer Treatment Centers of America: https://
7.    Herbst RS, Morgensztern D and Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018; 553: 446.
8.    Duma N, Davila RS and Molina JR. Non-small cell lung cancer: epidemiology screening, diagnosis and treatment. Mayo Clin. Proceedings. 2019; 94(8): 1624-1625.
9.    Pierre Fabre Medicament. Internal report. 1993; 259(2): 36.
10.    National Cancer Institute: ConceptReport.jsp?dictionary=NCI_Thesaurusandns=NCI_Thesaurusandcode=C1275.
11.    Chun R, Garrett LD and Vail DM. Cancer Chemotherapy. Withrow and Macewen’s Small Animal Clinical Oncology, Edited by Wthrow SJ and Vail DM. 2007; 4th ed: pp.166.
12.    Wang LG, Liu XM, Kreis W and Budman DR. The effect of antimicrotubule agent on signal transduction pathway of apoptosis: a review. Cancer Chemother. Pharmacology. 1999; 44: 355-361.
13.    Wang LG, Xiu XM and Chao DL. Activation of MAP kinase by vinorelbine in MCF-7 cells. Proc. Am. Assoc. Cancer Res. 1999; 40: 13.
14.    National Library of Medicine: compound/Vinorelbine#section=Absorption-Distribution-and-Excretion
15.    Caffo O, Dipasquale M, Murgia V, Veccia A and Galligioni E. An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment. Expert Opinion on Drug Metabolism and Toxicology. 2013; 9(8): 1039.
16.    Goa KL and Faulds D. Vinorelbine: a review of its pharmacological properties and clinical use in cancer chemotherapy. Drug and Aging. 1994; 5(3): 209.
17.    Krikorian A and Breillont F. Vinorelbine (Navelbine). a new semisynthetic vinca alkaloid. Oncol. Res. And Treatment. 1991; 14(1): 8-10.
18.    Bahadori F, Topcu G, Eroglu MS and Onyuksel H. A new lipid-based nano formulation of vinorelbine. AAPS Pharm SciTech. 2014; 15(5): 1147.
19.    Morimoto Y, Miyawaki K, Seki R, Watanabe K, Hirohara M and Shinohara T. Risk factors of venous irritation in patients receiving vinorelbine: a retrospective study. J. of Pharm. Health Care and Sci. 2018; 4(1): 1.

Recomonded Articles:

Author(s): Manju Rawat, SJ Daharwal, Deependra Singh

DOI:         Access: Open Access Read More

Author(s): Sonte Sushmitha, Sedimbi Revathi Priyanka, L. Mohan Krishna, M. Srinavasa Murthy

DOI: Not Available         Access: Open Access Read More

Author(s): Y. Prem Kumar, K. Vinod Kumar, V. Sai Kishore

DOI: Not Available         Access: Open Access Read More

Author(s): Mohammed Ehtesham Ur Rahman, Mohammed Abdul Haseeb, Mohammed Saleem, Abdul Naveed

DOI: Not Available         Access: Open Access Read More

Author(s): Jayesh M Jain, Dinesh M Sakarkar, Shajahan Abdul, Mangesh E Bhad, Anil V Chandewar and Sunil B Jaiswal

DOI: Not Available         Access: Closed Access Read More

Author(s): YK Naidu, Raghunadha Reddy S, Koteswara Rao Divi, MP Kalyan Reddy, I Sarath Chandiran, KN Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Manojkumar K. Munde, Nilesh S. Kulkarni, Nikita B. Rukhe, Dhanya B. Sen

DOI: 10.5958/0974-360X.2020.00616.2         Access: Closed Access Read More

Author(s): Arnab Samanta*, Amitava Roy, Mrityunjoy Majumdar

DOI: 10.5958/0974-360X.2018.00124.5         Access: Open Access Read More

Author(s): Rajanikanta Sahu, Tapas Kumar Mohapatra, Bharat Bhusan Subudhi

DOI: 10.5958/0974-360X.2018.00946.0         Access: Open Access Read More

Author(s): Khokhlenkova NV, Yarnykh TG, Buryak MV

DOI: Not Available         Access: Open Access Read More

Author(s): Sushant S Dhavale, AV Bhosle, SR Hardikar, Tushar R Kotkar

DOI:         Access: Open Access Read More

Author(s): Dhanish Joseph, Golda Maria Thomas

DOI: 10.5958/0974-360X.2019.00427.X         Access: Open Access Read More

Author(s): Chopade Tanaji, Baokar Shrikrishna, Joshi H.A., Patil R.N.

DOI: 10.5958/0974-360X.2017.00333.X         Access: Open Access Read More

Author(s): Sri Hartati Yuliani, Dina Christin Ayuning Putri, Aris Widayati, Bagas Abiyoga

DOI: 10.5958/0974-360X.2020.01086.0         Access: Closed Access Read More

Author(s): Janani SK, R. Suresh Kumar, Chenmala Karthika, Vasanthi C, Shaik Rafi Kapoor

DOI: 10.5958/0974-360X.2019.00543.2         Access: Open Access Read More

Author(s): U.S. Mahadeva Rao, Khamsah Suryati Mohd, Atif AB, Ahmad Zubaidi Bin A. Latif

DOI: Not Available         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles